Tag Archives: Judge O’Malley

Roche Molecular Systems, Inc. v. Cepheid – Are Primers “Natural Products”?

Posted on October 9, 2018 by Warren Woessner

Anyone familiar with the fate of claims to primers used in PCR, to amplify a stretch of target DNA in order to determine whether or not a significant mutation is present, could write the opinion in this appeal (No. 2017-1690 … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged biotechnology patent law, BRCA DNA, Federal Circuit, Judge O'Malley, M. tuberculosis, MTB, Myriad, nucleotides, PCR, Section 101, Warren Woessner | 1 Comment

Saffran v. J&J – When Defining Equals Disclaiming

Posted on April 17, 2013 by Warren Woessner

A guest post from Theresa Stadheim of Schwegman Lundberg & Woessner, P.A. In Bruce N. Saffran, M.D., Ph.D., v. Johnson & Johnson and Cordis Corporation, Appeal No. 2012-1043 (Fed. Cir. April 4, 2013, decision by Lourie), the Federal Circuit reversed … Continue reading →

Posted in Claim Interpretation | Tagged Bruce N. Saffran, Cordis Corporation, Federal Circuit, Johnson & Johnson, Judge O'Malley, Patent Law, Phillips v. AWH, Warren Woessner | Leave a comment

Eurand v. Mylan –A “School Of Obviousness”

Posted on April 20, 2012 by Warren Woessner

When I read the April 16th decision (App. No. 2011-1399, -1409 (Fed. Cir. April 16, 2012)) (a copy is available at the end of this post) in which a Fed. Cir. panel of Newman, O’Malley and Reyna reversed a district … Continue reading →